Coherus Identifies Stealing Amgen’s Crown As Pegfilgrastim Market Leader

Plans To Avoid ‘Resorting To Disproportionate Discounting’ Of Other Biosimilars

 
• By Dean Rudge
  
Arrows
Coherus is aiming to rise above innovator Amgen • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products